Picture of Annexon logo

ANNX Annexon Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Annexon, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-37.2-63.4-130-142-134
Depreciation
Non-Cash Items7.714.9418.819.816.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.6254.723.283.74-5.8
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-28.4-53.1-106-116-121
Capital Expenditures-0.267-0.464-1.65-6.53-0.193
Purchase of Fixed Assets
Other Investing Cash Flow Items-82.7-86.66570.9
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.267-83.2-88.258.470.7
Financing Cash Flow Items-1.6-2.970-7.99
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities28.43611.79123136
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.244225-1936585.1